🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Instituto Grifols S.A. — Licensed Medicines

10 medicines held by Instituto Grifols S.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 10 products held by Instituto Grifols S.A.
MedicineActive substanceLicence holderStatus
Albutein, 200 gram(s)/litre, solution for infusion
PA0849/006/002
Human albumin solution Instituto Grifols S.A. Not marketed
Albutein, 50 gram(s)/litre, solution for infusion
PA0849/006/001
Human albumin solution Instituto Grifols S.A. Not marketed
Fanhdi 1000 IU powder and solvent for solution for injection
PA0849/001/003
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Fanhdi 250 IU powder and solvent for solution for injection
PA0849/001/001
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Fanhdi 500 IU powder and solvent for solution for injection
PA0849/001/002
Human coagulation factor viii Instituto Grifols S.A. Not marketed
Flebogamma
EU/1/07/404/1-5
Human normal immunoglobulin Instituto Grifols S.A.
Flebogamma DIF
EU/1/07/404/006-008
Human normal immunoglobulin Instituto Grifols S.A.
Tavlesse
EU/1/19/1405/002
FOSTAMATINIB Instituto Grifols S.A.
VeraSeal 80 mg/ml/500 IU/ml Solutions for sealant
EU/1/17/1239/001-002
Human fibrinogen Instituto Grifols S.A.
VeraSeal 80 mg/ml/500 IU/ml Solutions for sealant
EU/1/17/1239/003-004
Human fibrinogen Instituto Grifols S.A.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.